Videos

Inna Tsuker, PharmD, BCPS, Cancer Treatment Centers of America, discusses the Qutenza patch, a little-known treatment for neuropathic pain.

Sheila Hunt, RN, Baylor Scott and White McClinton Cancer Center, discusses how she manages day-to-day stress as an oncology nurse.

Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treatment for lymph node-positive bladder cancer.

Gary H. Lyman, MD, MPH, Fred Hutchinson Cancer Research Center, discusses the immediate and long-term effects of febrile neutropenia.

Jean Sellers, RN, MSN, administrative clinical director, UNC Lineberger Comprehensive Cancer Center, discusses how to be a successful oncology nurse navigator.

Mary S. McCabe, RN, MA, discusses an evaluation of nurse practitioner-led survivorship care.

Joel Stettler, BSN, RN, OCN, Moffitt Cancer Center, discusses common causes for falls in the inpatient malignant hematology population, and what can be done to reduce these incidents.

Ryan Nipp, MD, discusses a study of symptom burden and hospital length of stay in patients with incurable cancer.

Donna Clark, RN, Mitchell Cancer Institute, discusses the difference that a caring oncology nurse can make for patients.

Kyung Chu, RN, NYU Langone Perlmutter Cancer Center, discusses treating patients with different subtypes of KRAS mutation.

Jeannine Brant, PhD, APRN-CNS, AOCN, of the Billings Clinic in Montana, discusses the importance of assessing and managing breakthrough cancer pain.

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, discusses the role of oncology nurses in handling sleep disturbances.

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

Colleen O’Leary, associate director for nursing education, The Ohio State University James Cancer Hospital, discusses the vital role nurses play in guiding the treatment of their patients with cancer.

Inna Tsuker, PharmD, BCPS, Cancer Treatment Centers of America, discusses a team-based approach implemented to prevent patients with cancer from falling.

Darcy Burbage, RN, MSN, AOCN, CBCN, Helen F. Graham Cancer Center & Research Institute, discusses risk factors that oncology nurses should be aware of when thinking about chemotherapy-induced peripheral neuropathy (CIPN).

​Joan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.

Paloma Pearson, manager of clinical operations, Baylor Scott and White Hillcrest Medical Center, talks about how technology is changing the landscape of healthcare.

Caitlin Braithwaite, BAN, RN, OCN, University of Iowa Hospitals and Clinics, discusses her use of hand massage in patients with cancer, and what her fellow nurses thought of the implementation.

Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.

Norman E. Sharpless, MD, Professor of Medicine & Genetics Chair, The Lineberger Comprehensive Cancer Center, discusses a recent study that evaluated sunscreen’s effectiveness in reducing melanoma risk.

Barry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer.

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses nurses’ roles in treating patients receiving immunotherapy, especially combination checkpoint blockades, which are typically associated with higher risks of adverse events.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.

Jae Park, MD, Memorial Sloan Kettering Cancer Center, explains CAR T-cell therapy, which is currently being investigated in patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma.

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade.